Editorial Article Open Access Catecholamine Homeostasis & Executive Function

Posttraumatic Stress Disorder, Complex PTSD, and Attention-Deficit/Hyperactivity Disorder: Comorbidity and Shared Mechanisms

Published: 11 May 2026 · Olympia R&D Bulletin · Permalink: olympiabiosciences.com/rd-hub/ptsd-cptsd-adhd-comorbidity-mechanisms/ · 27 sources cited · ≈ 14 min read
Posttraumatic Stress Disorder, Complex PTSD, and Attention-Deficit/Hyperactivity Disorder: Comorbidity and Shared Mechanisms — Catecholamine Homeostasis & Executive Function scientific visualization

Industry Challenge

The high comorbidity and overlapping symptomatology of PTSD, CPTSD, and ADHD present a key challenge. Developing precise therapies requires unraveling their complex, shared neurobiological mechanisms.

Olympia AI-Verified Solution

Olympia Biosciences leverages advanced AI and neuro-metabolic profiling to identify distinct biomarkers and pathways, enabling the development of targeted therapeutic agents for complex neuropsychiatric comorbidities.

💬 Not a scientist? 💬 Get a plain-English summary

In Plain English

Many people struggle with conditions like PTSD (from trauma), Complex PTSD (from long-term trauma), and ADHD (trouble with focus), and these often occur together, making them difficult to distinguish. These conditions share confusing symptoms, such as difficulty concentrating, but the underlying reasons can be very different; for instance, trouble focusing might stem from constant alertness in PTSD, or from a primary brain difference in ADHD. This overlap often leads to misdiagnosis or missed trauma-related issues. Understanding the unique brain processes involved in each condition, despite their similar outward signs, is essential for creating more accurate and effective treatments.

Olympia already has a formulation or technology that directly addresses this research area.

Talk to us →

Introduction

The empirical literature synthesized here centers on intersections between posttraumatic stress disorder (PTSD), attention-deficit/hyperactivity disorder (ADHD), and trauma-related complex presentations that are often discussed as “complex trauma,” with most direct quantitative evidence in this corpus focused on PTSD–ADHD comorbidity rather than ICD-11 Complex PTSD (CPTSD).[1–3] In the included studies, PTSD and ADHD are operationalized using DSM-based diagnostic criteria and symptom dimensions (e.g., PTSD diagnosis and DSM-IV inattentive vs hyperactive-impulsive ADHD symptom domains), enabling comparisons of prevalence, symptom severity associations, and overlap in specific symptom clusters rather than relying on purely theoretical alignment between disorders.[1, 4]

A recurring clinical motivation across the evidence is that PTSD and ADHD can be confused because they share surface features such as concentration problems, yet the putative mechanisms differ (e.g., PTSD-related concentration impairment arising from hypervigilance and intrusive memories vs neurodevelopmental ADHD-related inattention).[5, 6] This diagnostic ambiguity matters because it can contribute to variable comorbidity estimates across studies and may drive either missed trauma-related pathology or mistaken attribution of trauma-related cognitive symptoms to ADHD.[5, 7]

Although ICD-11 CPTSD-specific measurement is sparse in the provided evidence, several included sources explicitly connect chronic childhood adversity (“complex trauma”) to ADHD symptomatology and to developmental processes such as mentalization, implying potential conceptual bridges to CPTSD’s self-organization difficulties even when CPTSD is not formally assessed.[2] Accordingly, the present synthesis treats “CPTSD” as a clinically relevant but under-measured construct in this evidence packet and foregrounds what can be inferred from studies that examine complex trauma exposure, dissociation, and emotion dysregulation as potential linking mechanisms between PTSD and ADHD symptom profiles.[2, 8, 9]

Methods

This review was generated using a PRISMA-style funnel that began with approximately 600 records retrieved across 10 broad academic queries spanning PTSD–ADHD comorbidity, symptom overlap, developmental trauma pathways, differential diagnosis, emotional dysregulation, and neurobiological mechanisms, with 343 records retained after an initial relevance screen, 196 after a stricter cross-disorder intersection screen, and 50 full-text papers forming the final synthesis set.[10] The theme-level synthesis presented below is therefore a structured narrative integration of the extracted findings, emphasizing quantitative comorbidity metrics (prevalence ratios, adjusted odds ratios, hazard ratios), symptom-level associations, and mechanistic models (e.g., dissociation mediation and inhibitory-control overlap).[11–13]

Comorbidity and prevalence

Across adult and military/veteran samples, ADHD and PTSD co-occur at clinically meaningful rates, with estimates varying substantially by sampling frame and ascertainment (PTSD-selected clinical samples, combat-exposed cohorts, inpatient substance-use settings, and population registers).[1, 11, 14] In a PTSD-selected veteran clinical sample, 11.5% of those meeting DSM-IV-TR criteria for PTSD also met DSM-IV-TR criteria for current ADHD, indicating a sizable comorbid subgroup even within a PTSD-defined cohort.[1] In another veteran sample (n=332), 9.0% met criteria for both ADHD and PTSD, while 44.3% had PTSD only and 3.6% had ADHD only, illustrating that “double-diagnosis” is not rare in trauma-exposed military populations but also that either condition can occur in isolation in the same setting.[11]

Several studies further suggest that ADHD symptoms or history are associated with increased probability of PTSD diagnosis and/or symptom severity, supporting a “risk marker” or vulnerability interpretation in some contexts.[11, 12, 15] In combat-exposed veterans, meeting criteria for childhood ADHD on the WURS-25 was associated with higher prevalence of lifetime PTSD (PR=2.53, 95% CI [1.11, 7.28]) and current PTSD (PR=2.19, 95% CI [1.17, 4.38]).[11] In a prospective cohort of U.S. Army soldiers, predeployment ADHD was strongly associated with later postdeployment past-month PTSD even after extensive adjustment (AOR=2.13, 95% CI [1.51, 3.00]) and also predicted PTSD incidence among those without baseline lifetime PTSD (AOR=2.50, 95% CI [1.69, 3.69]).[12]

Large registry and family-comparison evidence likewise supports elevated PTSD prevalence and incidence among individuals with ADHD, while also indicating that familial factors do not fully explain the association.[13] In the cited register study, individuals with ADHD had PTSD prevalence 15.02 (95% CI 14.19–15.9) compared to 1.62 (95% CI 1.56–1.67) among individuals without ADHD, yielding a prevalence ratio of 9.30 (95% CI 8.70–9.93).[13] In a sibling-comparison design within the same source, individuals diagnosed with ADHD were at higher hazard of developing PTSD than undiagnosed siblings (HR=2.37, 95% CI 1.98–3.53), suggesting that shared familial background alone is insufficient to account for the observed association.[13]

Clinical comorbidity can be particularly elevated in high-severity, high-comorbidity treatment settings, where selection effects and shared risk factors may concentrate both ADHD and PTSD.[14] In an alcohol use disorder (AUD) inpatient sample, PTSD prevalence was 84% among patients with self-reported adult ADHD versus 40% among those without self-reported adult ADHD (p<.001), and self-reported adult ADHD remained strongly associated with PTSD diagnosis after adjustment (Wald chi-square=46.8; p<.001).[14]

The literature also indicates that comorbidity patterns vary by sex/gender, at least in aggregate meta-analytic summaries of ADHD/PTSD comorbidity odds.[10] A fixed-effects meta-analysis (n=13,585) found higher odds of comorbid ADHD/PTSD in females compared with males overall (OR=1.32, 95% CI [1.04, 1.66]) and in adult studies (OR=1.41, 95% CI [1.08, 1.86]), while pediatric studies did not show significant sex differences (OR=1.08, 95% CI [0.67, 1.70]).[10]

At the symptom-severity level, evidence indicates that ADHD symptom burden may account for incremental variance in PTSD severity beyond trauma exposure, which is consistent with either a shared mechanism or an exacerbation model in comorbid presentations.[15, 16] Specifically, one study reported that current ADHD severity predicted PTSD severity and accounted for an additional 7% of variance in current PTSD severity above and beyond trauma exposure.[15, 16]

The table below consolidates selected quantitative comorbidity findings reported across the included sources to highlight the magnitude and heterogeneity of observed associations.

Symptom overlap

A consistent theme across overlap-focused studies is that PTSD and ADHD may be linked partly through overlapping symptom content and related processes (e.g., dissociation), rather than solely through independent comorbid disorders occurring together by chance.[8, 17] In community samples of earthquake survivors, multivariate analyses indicated that significant associations between PTSD and ADHD “resulted from symptom overlaps,” and pathological dissociation mediated the relationship between PTSD and ADHD symptoms, suggesting that dissociation is a plausible bridging process in trauma-exposed populations who also report ADHD-like symptoms.[8] Parallel findings were reported in a second dataset with similar analytic framing, again noting significant associations of ADHD symptoms and dissociation with PTSD and the mediation of PTSD–ADHD relations by pathological dissociation.[17]

Symptom overlap is also visible when examining ADHD symptom subdomains as they present among people with PTSD diagnoses, with some studies reporting elevated endorsement of inattention/memory problems and emotional lability/impulsivity among PTSD cases.[18] In one study, participants diagnosed with PTSD endorsed greater inattention/memory problems (F(1,93)=14.59, p<.01), hyperactivity/restlessness (F(1,93)=3.89, p=.05), and impulsivity/emotional lability (F(1,93)=10.13, p<.01) than those without PTSD.[18] In the same study, PTSD severity (CAPS-Total) was predicted by inattention/memory problems (β=.32, p<.01) and impulsivity/emotional lability (β=.23, p<.05) but not hyperactivity/restlessness (β=-.01, p=.92) after controlling for combat exposure, which implies that “ADHD-like” correlates of PTSD severity may cluster more strongly around inattention and emotional lability than around motoric hyperactivity in some trauma-exposed samples.[18]

Overlap may also reflect shared or altered cognitive control mechanisms that manifest as distractibility, disorganization, and difficulty suppressing intrusive thoughts, creating ambiguity about whether symptoms represent ADHD, PTSD, both, or a shared downstream cognitive-control dysfunction.[19] One interpretation offered in the evidence packet is that inattention in ADHD and avoidance symptoms in PTSD may reflect similar changes in cognitive control mechanisms, with problems of distraction/disorganization in ADHD and difficulty suppressing intrusive thoughts in PTSD aligning with alterations in inhibitory control.[19]

Notably, when clinician-rated symptom counts are available, the pattern can differ by ADHD dimension, with inattentive symptoms sometimes showing stronger association with PTSD severity than hyperactive-impulsive symptoms.[20] In one trauma-exposed adolescent sample, clinician-rated inattentive symptom count was strongly correlated with clinician-rated PTSD symptom severity (Spearman’s ρ=.53, p=.030), whereas the hyperactive-impulsive symptom count showed a weak, non-significant correlation with PTSD severity (ρ=-.11, p=.689).[20]

Neurobiology

The neurobiological evidence available in this packet is limited to a single integrative review, which frames PTSD and ADHD as sharing executive-function (EF) impairments and frontal–subcortical circuit changes relevant to psychopathological processes in both disorders.[21] Within that review’s synthesis, overlapping neural substrates are emphasized for ADHD and PTSD symptomatology, especially regarding inhibitory control as a key EF component that may contribute to cognitive and emotional dysregulation across disorders.[21]

The same review argues that irregularities in neural mechanisms are associated with symptom severity in both ADHD and PTSD and are described globally as deficits in attentional systems, linking clinical symptom expression to system-level attentional dysfunction rather than to a single localized neural marker.[21] The review also describes structural and functional abnormalities in a broad circuit that includes frontal and medial areas, cingulate cortex and thalamus, hippocampal formation, and the amygdaloid complex, which collectively provides a plausible neurocircuitry framework for understanding how attention/executive deficits and threat/emotion-related dysregulation could co-occur.[21]

Because the neurobiology theme is represented by a single review in the provided evidence, the present synthesis treats these claims as hypothesis-generating and integrative rather than as a multi-study quantitative consensus within this dataset.[21]

Differential diagnosis

Differential diagnosis is a prominent concern in the PTSD–ADHD intersection literature because overlapping symptoms (especially concentration difficulties) can lead to misclassification, with ADHD and PTSD described as “quite often confused” in at least one child-focused discussion of diagnostic problems.[6] That source explicitly frames the problem as one in which clinicians across psychology, education, and psychiatry struggle to identify the pathomechanisms underlying children’s behavioral difficulties, motivating comparative symptom mapping and identification of essential elements for differential diagnosis.[6]

A clinically actionable principle in the included evidence is that similar surface symptoms can reflect different mechanisms and therefore different clinical implications, as summarized by the observation that concentration difficulties occur in both ADHD and PTSD but that PTSD-related concentration impairment typically results from hypervigilance and intrusive memories whereas ADHD-related inattention is neurodevelopmental.[5] This differentiation supports the notion that apparent comorbidity may sometimes reflect symptom mimicry (PTSD-driven attentional disruption) rather than two independent disorders co-occurring, even while other evidence supports genuine co-occurrence and risk pathways.[5, 6]

Empirical pediatric evidence in a war-exposed sample further illustrates how trauma-related symptoms can account for attention problems in ways that complicate ADHD inference when trauma is not assessed.[22] In that sample, 41% met cutoffs for clinically significant interviewer-reported PTSD symptoms and 65.1% for clinically significant self-reported PTSD symptoms, whereas teacher-rated clinically significant attention problems were 5.2%, highlighting a setting where trauma symptoms are widespread and attention problems are less prevalent at a clinical threshold.[22] Children with clinically significant interviewer-reported PTSD symptoms had higher prevalence of clinically significant attention problems (8%) than children without clinically significant interviewer-reported PTSD symptoms (2.5%), indicating a trauma-symptom-linked elevation in attention problems within the same sample.[22] When interviewer-reported PTSD symptoms were added to a model, the standardized coefficient for the exposure–attention relationship decreased to .02 and became non-significant, supporting the hypothesis that PTSD symptoms mediate relations between trauma exposure and attention problems and reinforcing the differential diagnostic importance of assessing trauma symptoms when attention problems are observed.[22]

Consistent with this, a specific screening recommendation is offered: because the trauma exposure–attention link can be “potentially spurious,” children with poor concentration and hyperactivity should be screened for trauma exposure, and those with positive histories should be screened for trauma symptoms.[22]

At the same time, differential diagnosis is complicated by evidence that ADHD symptoms can predict later PTSD symptom outcomes over short time frames in a military training context, suggesting that ADHD symptom burden may sometimes function as a vulnerability marker rather than merely an artifact of PTSD symptom expression.[23] In that study, present ADHD symptoms (OR=1.145, p=0.001) and past ADHD symptoms (OR=1.049, p=0.028) were significant risk factors for PTSD symptoms in the first week of basic training, and PTSD symptoms in the first week predicted PTSD symptoms after five weeks (OR=1.073, p=0.006).[23]

Developmental pathways

The developmental-trauma literature in this packet emphasizes that early chronic adversity (“complex trauma”) may be tightly intertwined with ADHD symptomatology and related developmental processes, suggesting one pathway for observed correlations between ADHD symptoms and later trauma-related syndromes.[2] One included source argues that chronic adverse childhood situations (complex trauma) “cannot be extricated from ADHD symptomatology” and is strongly correlated with behaviors common among children with deficits in psychological processes such as mentalization, which provides a developmental framing that links interpersonal adversity, self-regulatory development, and ADHD-like behavioral patterns.[2] In hospitalized children, attachment and environmental complex trauma events were reported as more common among children diagnosed with ADHD (97%) than among non-ADHD children (75%), supporting the association between early adversity contexts and ADHD diagnosis in a high-acuity clinical setting.[2]

In adults with ADHD, the developmental adversity signal is reflected in elevated adverse childhood experiences (ACEs) and co-elevation of PTSD and dissociative symptoms, suggesting that trauma-related processes may contribute to adult psychopathology profiles in ADHD populations.[9] Specifically, one study reports that the ADHD group had higher PTSD Checklist (PCL), Dissociative Experiences Scale (DES), and ACE scores, and that dissociative symptoms and PTSD-associated symptoms were more common in the ADHD group.[9] In the same dataset, ASRS inattentiveness was associated with emotional abuse (CTQ), dissociation (DES), and PTSD symptoms (PCL), indicating that both inattentive symptoms and trauma-linked symptom dimensions co-vary in adults with ADHD.[9]

These adult data also support a mechanistic interpretation in which dissociation and PTSD symptoms may account for variance in broader psychopathology that might otherwise be attributed to ADHD severity alone.[9] In the cited regression analysis, general psychopathology increased with increasing ASRS hyperactivity/impulsivity, but the association was no longer significant after DES and PCL scores were added, implying that dissociation and PTSD symptoms can explain a portion of the apparent relationship between ADHD hyperactivity/impulsivity and general psychopathology measures.[9]

Beyond postnatal trauma exposure, prenatal maternal PTSD exposure is associated with offspring ADHD diagnosis in register-based cohort data, supporting a developmental risk pathway that begins before birth and may involve biological, environmental, or combined mechanisms.[24] In the total population, children exposed to prenatal PTSD had 79% higher likelihood of ADHD diagnosis in the crude model (OR=1.79, 95% CI 1.37–2.34), and the association remained significant after adjustment for child sex, birth year, parental ages, family situation, income, and parental country of birth (OR=1.62, 95% CI 1.23–2.13).[24] In a subpopulation excluding parental ADHD and excluding maternal psychiatric diagnoses other than PTSD, the association remained (crude OR=2.72, adjusted OR=2.32), supporting the interpretation that the prenatal PTSD–offspring ADHD association persists even in strata designed to reduce confounding by parental ADHD or other maternal psychiatric conditions.[24]

Finally, developmental and overlap pathways can intersect via dissociation, as some trauma-exposed community studies indicate that pathological dissociation mediates PTSD–ADHD associations and that significant associations may result from symptom overlaps rather than ADHD being a primary vulnerability factor for post-traumatic stress response.[25] In one community study, authors concluded that ADHD comorbidity was not a predominant vulnerability factor for development of post-traumatic stress response but may exacerbate symptoms after PTSD develops, suggesting a developmental course where ADHD-like traits intensify post-traumatic symptom expression without necessarily increasing initial vulnerability in all contexts.[25]

Emotional dysregulation

Emotional dysregulation emerges as a transdiagnostic construct in the provided evidence through studies showing that PTSD status is associated with elevated ADHD symptom severity and that ADHD symptom severity contributes unique variance to affective dysregulation outcomes even after accounting for PTSD symptoms and major depressive disorder (MDD).[4] In adult smokers, the PTSD group endorsed significantly more severe DSM-IV inattentive and hyperactive-impulsive ADHD symptoms than those without PTSD, highlighting co-occurring ADHD symptom burden in PTSD cases.[4, 26]

Crucially, after partialling variance accounted for by PTSD symptoms and MDD diagnosis, ADHD symptoms were still significantly associated with lower positive affect, higher negative affect, higher emotion dysregulation, higher anxiety sensitivity, and higher urges to smoke to increase positive affect, with an additional association approaching significance for urges to smoke to improve negative affect.[4, 26] In the same study, effect sizes for PTSD-group differences in ADHD symptom severity were large (η²=.28 for inattentive symptoms and η²=.23 for hyperactive-impulsive symptoms), supporting the clinical relevance of ADHD symptom burden in PTSD populations and its potential contribution to affect-regulation difficulties.[4, 26]

Within the constraints of this evidence packet, these findings support emotional dysregulation as a plausible shared mechanism linking PTSD and ADHD symptom profiles, while also motivating more explicit tests of mediation or temporal sequencing in future work (particularly for CPTSD presentations characterized by pervasive affective dysregulation).[4]

CPTSD and ADHD

Direct ICD-11 CPTSD–ADHD comorbidity studies are largely absent from the provided evidence packet, and much of what is available instead addresses PTSD–ADHD intersections and “complex trauma” exposures without formal CPTSD measurement.[2, 3] The clearest CPTSD-relevant bridge within this packet is the developmental framing of chronic adversity (“complex trauma”) as intertwined with ADHD symptomatology and linked to mentalization-related deficits, which resembles the broader clinical concern that pervasive trauma may shape self-regulation, attention, and interpersonal functioning in ways that can be mistaken for or co-occur with ADHD.[2]

A second CPTSD-relevant bridge is the repeated implication of dissociation as a mediator of PTSD–ADHD associations, because dissociation is often discussed clinically in relation to complex trauma presentations and may plausibly contribute to disturbances in self-organization even though those CPTSD-specific domains are not measured here.[8, 25] In earthquake-survivor studies, pathological dissociation mediated relations between PTSD and ADHD symptoms and PTSD–ADHD associations were described as resulting from symptom overlaps, highlighting how trauma-linked dissociation could contribute to ADHD-like attentional/cognitive complaints in trauma-exposed individuals.[8, 17]

Finally, the differential-diagnosis literature’s caution that PTSD-related concentration impairment may arise from hypervigilance and intrusive memories rather than neurodevelopmental inattention is likely relevant to CPTSD presentations as well, insofar as chronic trauma syndromes can include pervasive threat-monitoring and intrusive phenomena alongside emotion dysregulation and attentional disruption.[5, 22] However, because CPTSD itself is not operationalized in the included overlap and comorbidity studies, the CPTSD–ADHD correlation remains an open empirical question in this packet, requiring targeted ICD-11 CPTSD assessment alongside ADHD diagnostic and symptom measures.[3]

Synthesis and future directions

Across the evidence synthesized here, the most consistent correlational pattern is that ADHD is associated with elevated PTSD prevalence, PTSD symptom severity, and/or prospective PTSD risk in adult and military/veteran contexts, while effect sizes and prevalence estimates vary markedly across clinical and community settings.[1, 12, 13] Quantitative findings spanning PTSD-selected veterans (11.5% ADHD among PTSD cases), combat-exposed veterans (PRs >2 for PTSD among childhood ADHD positives), prospective military cohorts (AORs ≈2–2.5), AUD inpatients (PTSD prevalence 84% vs 40% by adult-ADHD self-report), and national register data (PTSD prevalence ratio 9.30; sibling HR 2.37) collectively support a non-trivial association between ADHD and PTSD outcomes that is unlikely to be explained by chance alone in adult samples.[1, 11–13]

Mechanistically, several lines of evidence within this packet imply that symptom overlap and shared regulatory processes may contribute to observed correlations, including (a) dissociation-mediated PTSD–ADHD relations and explicit claims that associations can result from symptom overlap, (b) arousal-modulation shared variance (hyperarousal/hyperactivity and hypoarousal/emotional numbing), and (c) inhibitory-control and executive-function overlap as described in a neurobiological review.[8, 27] These patterns suggest that transdiagnostic constructs—arousal regulation, dissociation, inhibitory control, and emotion dysregulation—may be useful in explaining why ADHD and PTSD symptoms cluster in some individuals and why comorbidity estimates fluctuate with measurement and population characteristics.[9, 21, 27]

At the same time, important boundary conditions emerge, particularly in pediatric samples where ADHD diagnosis does not always correspond to higher PTSD prevalence and where informant disagreement on PTSD criteria can be extreme, indicating measurement challenges that likely affect comorbidity estimation and differential diagnosis in youth.[7] This is consistent with evidence that trauma-related symptoms can mediate exposure–attention links and with explicit guidance to screen for trauma exposure and trauma symptoms when attention/hyperactivity complaints occur, underscoring that PTSD can mimic ADHD-like symptoms and that careful history and symptom-context evaluation is central to diagnostic clarity.[22]

The CPTSD–ADHD intersection remains under-evidenced in the provided studies, despite multiple sources linking chronic adversity (“complex trauma”) to ADHD symptomatology and developmental processes such as mentalization and despite the repeated appearance of dissociation and emotion dysregulation as bridging mechanisms that are clinically salient for complex trauma syndromes.[2, 4, 25] Future research priorities implied by this packet include (1) direct studies measuring ICD-11 CPTSD alongside ADHD (diagnosis and dimensional symptoms) to establish CPTSD-specific prevalence and correlates, (2) longitudinal designs that test whether ADHD traits prospectively increase risk for PTSD/CPTSD versus primarily exacerbating symptoms after onset, and (3) mechanistic models that simultaneously evaluate dissociation, emotion dysregulation, and inhibitory-control dysfunction as potential mediators of observed PTSD–ADHD correlations.[21, 23, 25]

Author Contributions

O.B.: Conceptualization, Literature Review, Writing — Original Draft, Writing — Review & Editing. The author has read and approved the published version of the manuscript.

Conflict of Interest

The author declares no conflict of interest. Olympia Biosciences™ operates exclusively as a Contract Development and Manufacturing Organization (CDMO) and does not manufacture or market consumer end-products in the subject areas discussed herein.

Olimpia Baranowska

Olimpia Baranowska

CEO & Scientific Director · M.Sc. Eng. Applied Physics & Applied Mathematics (Abstract Quantum Physics & Organic Microelectronics) · Ph.D. Candidate in Medical Sciences (Phlebology)

Founder of Olympia Biosciences™ (IOC Ltd.) · ISO 27001 Lead Auditor · Specialising in pharmaceutical-grade CDMO formulation, liposomal & nanoparticle delivery systems, and clinical nutrition.

Proprietary IP

Interested in This Technology?

Interested in building a product around this science? We work with pharmaceutical companies, longevity clinics, and PE-backed brands to translate proprietary R&D into market-ready formulations.

Selected technologies may be offered exclusively to one strategic partner per category — initiate due diligence to confirm allocation status.

Discuss a Partnership →

References

27 sources cited

  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18.
  19. 19.
  20. 20.
  21. 21.
  22. 22.
  23. 23.
  24. 24.
  25. 25.
  26. 26.
  27. 27.

Global Scientific & Legal Disclaimer

  1. 1. B2B & Educational Purposes Only. The scientific literature, research insights, and educational materials published on the Olympia Biosciences website are provided strictly for informational, academic, and Business-to-Business (B2B) industry reference. They are intended solely for medical professionals, pharmacologists, biotechnologists, and brand developers operating in a professional B2B capacity.

  2. 2. No Product-Specific Claims.. Olympia Biosciences™ operates exclusively as a B2B contract manufacturer. The research, ingredient profiles, and physiological mechanisms discussed herein are general academic overviews. They do not refer to, endorse, or constitute authorized marketing health claims for any specific commercial dietary supplement, medical food, or end-product manufactured in our facilities. Nothing on this page constitutes a health claim within the meaning of Regulation (EC) No 1924/2006 of the European Parliament and of the Council.

  3. 3. Not Medical Advice.. The content provided does not constitute medical advice, diagnosis, treatment, or clinical recommendations. It is not intended to replace consultation with a qualified healthcare provider. All published scientific material represents general academic overviews based on peer-reviewed research and should be interpreted exclusively in a B2B formulation and R&D context.

  4. 4. Regulatory Status & Client Responsibility.. While we respect and operate within the guidelines of global health authorities (including EFSA, FDA, and EMA), the emerging scientific research discussed in our articles may not have been formally evaluated by these agencies. Final product regulatory compliance, label accuracy, and substantiation of B2C marketing claims in any jurisdiction remain the sole legal responsibility of the brand owner. Olympia Biosciences™ provides manufacturing, formulation, and analytical services only. These statements and raw data have not been evaluated by the Food and Drug Administration (FDA), the European Food Safety Authority (EFSA), or the Therapeutic Goods Administration (TGA). The raw active pharmaceutical ingredients (APIs) and formulations discussed are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this page constitutes a health claim within the meaning of EU Regulation (EC) No 1924/2006 or the U.S. Dietary Supplement Health and Education Act (DSHEA).

Our IP Pledge

We do not own consumer brands. We never compete with our clients.

Every formula engineered at Olympia Biosciences™ is built from scratch and transferred to you with full intellectual property ownership. Zero conflict of interest — guaranteed by ISO 27001 cybersecurity and ironclad NDAs.

Explore IP Protection

Cite

APA

Baranowska, O. (2026). Posttraumatic Stress Disorder, Complex PTSD, and Attention-Deficit/Hyperactivity Disorder: Comorbidity and Shared Mechanisms. Olympia R&D Bulletin. https://olympiabiosciences.com/rd-hub/ptsd-cptsd-adhd-comorbidity-mechanisms/

Vancouver

Baranowska O. Posttraumatic Stress Disorder, Complex PTSD, and Attention-Deficit/Hyperactivity Disorder: Comorbidity and Shared Mechanisms. Olympia R&D Bulletin. 2026. Available from: https://olympiabiosciences.com/rd-hub/ptsd-cptsd-adhd-comorbidity-mechanisms/

BibTeX
@article{Baranowska2026ptsdcpts,
  author  = {Baranowska, Olimpia},
  title   = {Posttraumatic Stress Disorder, Complex PTSD, and Attention-Deficit/Hyperactivity Disorder: Comorbidity and Shared Mechanisms},
  journal = {Olympia R\&D Bulletin},
  year    = {2026},
  url     = {https://olympiabiosciences.com/rd-hub/ptsd-cptsd-adhd-comorbidity-mechanisms/}
}

Executive protocol review

Article

Posttraumatic Stress Disorder, Complex PTSD, and Attention-Deficit/Hyperactivity Disorder: Comorbidity and Shared Mechanisms

https://olympiabiosciences.com/rd-hub/ptsd-cptsd-adhd-comorbidity-mechanisms/

1

Send Olimpia a note first

Let Olimpia know which article you'd like to discuss before booking your slot.

2

OPEN EXECUTIVE ALLOCATION CALENDAR

Select a qualification slot after submitting mandate context to prioritize strategic fit.

OPEN EXECUTIVE ALLOCATION CALENDAR

Express Interest in This Technology

We'll follow up with licensing or partnership details.

Article

Posttraumatic Stress Disorder, Complex PTSD, and Attention-Deficit/Hyperactivity Disorder: Comorbidity and Shared Mechanisms

No spam. Olimpia will review your signal personally.